Sort
25,944 grants matching “neurodegeneration”
Immunophilin ligands for HIV dementia and neuropathy
$1,414,090Johns Hopkins University · P01 · FY2003 · MH
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers
$1,413,975Allan I Levey · Emory University · U01 · FY2021 · AG
Remodeling and recovery in the neurovascular unit
$1,413,847Eng H. Lo · Massachusetts General Hospital · P01 · FY2015 · NS
PET Study of Biochemistry and Metabolism of the CNS
$1,413,686University Of Michigan At Ann Arbor · P01 · FY2005 · NS
Immunogenetic Determinants of Disease Risk in Neurological Disease
$1,413,302Jorge R. Oksenberg · University Of California, San Francisco · U19 · FY2015 · NS
DNA Repair in Human Cancer-Prone Genetic Diseases
$1,412,626Kenneth H Kraemer · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Leveraging Longitudinal Data and Informatics Technology to Understand the Role of Bilingualism in Cognitive Resilience, Aging and Dementia
$1,411,758Li Zhou · Brigham And Women'S Hospital · R01 · FY2023 · AG
Longitudinal Imaging Biomarkers of Disease Progression in DLB
$1,411,504Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2020 · NS
MAYO ALZHEIMERS DISEASE RESEARCH CENTER
$1,411,001Mayo Clinic Coll Of Medicine, Rochester · P50 · FY2001 · AG
Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal study
$1,410,492Ricardo S Osorio · New York University School Of Medicine · R01 · FY2018 · AG
Genetic models of sporadic Alzheimers Disease in the marmoset
$1,410,426Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2021 · AG
Genetic models of sporadic Alzheimers Disease in the marmoset
$1,410,426Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2022 · AG
Regional, Synaptic, Cellular Modulation of Abeta Metabolism
$1,408,551David M Holtzman · Washington University · P01 · FY2021 · NS
Multifunctional phase sensors for probing and manipulation of intracellular biomolecular condensates
$1,408,500Felipe Garcia Quiroz · Emory University · DP2 · FY2022 · GM
Childhood Neurodegenerative Lysosomal Storage Disorders
$1,407,388Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease
$1,407,306Ashok K. Shetty · Texas A&M University Health Science Ctr · RF1 · FY2025 · AG
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$1,406,475Nigel H. Greig · National Institute On Aging · ZIA · FY2019 · AG
Understanding the role of senescence on post-operative neuroinflammation
$1,405,555Shyni Varghese · Duke University · RF1 · FY2025 · AG
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
$1,404,983Cindy Ann Burklow · Naprogenix, Inc · U44 · FY2022 · AA
ROLE OF GLIA IN NEURONAL DEGENERATION
$1,404,268Northwestern University · P01 · FY2004 · AG
The neuronal stress response in neurodegenerative disease and pain
$1,403,918Claire Le Pichon · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
$1,403,404Linda J Van Eldik · University Of Kentucky · U01 · FY2016 · AG
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,403,277Linda J Van Eldik · University Of Kentucky · R01 · FY2019 · AG
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
$1,403,120Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,402,795Jie Shen · Brigham And Women'S Hospital · P50 · FY2019 · NS